Dresden-Hellerau, 1st October 2019. Biotype launches 3 new assays on its molecular diagnostic platform ModaplexTM:
The kits (research use only) enable the detection of 13 KRAS, 13 NRAS, and 4 BRAF (KNB) mutations together in a single run. The Modaplex system thus offers a fast, simple, and sensitive approach for a comprehensive KNB mutation analysis.
The 3 assays further broaden Biotype’s existing portfolio for the Modaplex system in the area of oncology.
Further information about all KNB assays can be found here.